SHANGHAI, May 4, 2025 /PRNewswire/ — On April 23, 2025, Nutshell Therapeutics ( Shanghai ) Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical trial in the United States for its NTS071, […]
Tag: Nutshell Therapeutics
#Rosal Top Picks
Recent Posts
- HELSINKI, Dec. 18, 2025 /PRNewswire/ —
- New role further strengthens marketing capabilities
- Business veteran brings robust sight for house
- HELSINKI, Dec. 18, 2025 /PRNewswire/ —
- -TCL mostrará el futuro con innovaciones visuales
